Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (SHE:301617)

Market Cap	4.71B
Revenue (ttm)	1.34B
Net Income (ttm)	211.06M
Shares Out	133.64M
EPS (ttm)	1.94
PE Ratio	18.15
Forward PE	n/a
Dividend	0.46 (1.31%)
Ex-Dividend Date	May 26, 2025

Volume	827,960
Average Volume	1,322,726
Open	36.00
Previous Close	35.11
Day's Range	34.87 - 36.00
52-Week Range	31.83 - 82.82
Beta	n/a
RSI	40.30
Earnings Date	May 19, 2025

About SHE:301617

Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. engages in the research and development, production, and sales of fine chemicals. The company offers iodine derivatives, such as potassium iodide, sodium iodide, potassium iodide, hydriodic acid, copper iodide, and iodotrimethylsilane; and fine chemicals, including hexamethyldisilazane, hexamethyldisilane, hexamethyldisiloxane, and tris[2-(2-methoxyethoxy)ethyl]amine. It also offers chemiluminescent products comprising 3,5-Dichlorosalicylic acid; 3,5,6-Trichlorosalicylic acid; bis(2,4,5-trichl...

• Industry: Industrial Inorganic Chemicals
• Founded: 2008
• Employees: 667
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301617

Financial Performance

In 2024, SHE:301617's revenue was 1.33 billion, an increase of 29.53% compared to the previous year's 1.03 billion. Earnings were 213.13 million, an increase of 17.04%.